Nautilus Biotechnology, Inc. (NAUT)
2.38
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
2.57
+0.19
(+7.98%)
After-Hours: 04:55
Nautilus Biotechnology Total Liabilities (Quarterly) : 33.36M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cytek Biosciences, Inc. | 121.47M |
| Agilent Technologies, Inc. | 5.905B |
| Inotiv, Inc. | 625.32M |
| Bio-Rad Laboratories, Inc. | 2.939B |
| Bruker Corp. | 3.628B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.78M |
| Shareholders Equity (Quarterly) | 144.42M |
| Debt to Equity Ratio | 0.1999 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | 0.07% |